rs869320752
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PM4_SupportingPP5_Very_Strong
The NM_021939.4(FKBP10):c.877_879delTAC(p.Tyr293del) variant causes a conservative inframe deletion change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 31)
Consequence
FKBP10
NM_021939.4 conservative_inframe_deletion
NM_021939.4 conservative_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.60
Genes affected
FKBP10 (HGNC:18169): (FKBP prolyl isomerase 10) The protein encoded by this gene belongs to the FKBP-type peptidyl-prolyl cis/trans isomerase (PPIase) family. This protein localizes to the endoplasmic reticulum and acts as a molecular chaperone. Alternatively spliced variants encoding different isoforms have been reported, but their biological validity has not been determined.[provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_021939.4. Strenght limited to Supporting due to length of the change: 1aa.
PP5
Variant 17-41819356-CACT-C is Pathogenic according to our data. Variant chr17-41819356-CACT-C is described in ClinVar as [Pathogenic]. Clinvar id is 208427.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FKBP10 | NM_021939.4 | c.877_879delTAC | p.Tyr293del | conservative_inframe_deletion | 5/10 | ENST00000321562.9 | NP_068758.3 | |
FKBP10 | XM_011525099.4 | c.877_879delTAC | p.Tyr293del | conservative_inframe_deletion | 5/11 | XP_011523401.1 | ||
FKBP10 | XM_011525100.3 | c.604_606delTAC | p.Tyr202del | conservative_inframe_deletion | 4/10 | XP_011523402.1 | ||
FKBP10 | XM_047436515.1 | c.604_606delTAC | p.Tyr202del | conservative_inframe_deletion | 4/9 | XP_047292471.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FKBP10 | ENST00000321562.9 | c.877_879delTAC | p.Tyr293del | conservative_inframe_deletion | 5/10 | 1 | NM_021939.4 | ENSP00000317232.4 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Osteogenesis imperfecta Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 23, 2024 | Variant summary: FKBP10 c.877_879delTAC (p.Tyr293del) results in an in-frame deletion that is predicted to remove one amino acid in the FKBP-type peptidyl-prolyl cis-trans isomerase domain (IPR001179) from the encoded protein. The variant was absent in 251136 control chromosomes. c.877_879delTAC has been reported at a homozygous state in the literature in multiple individuals affected with Kuskokwim syndrome. These data indicate that the variant is very likely to be associated with disease (Barnes_2013). At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in a residual 5% of normal FKBP65 protein levels due to destability and compromised hydroxylation levels of the telopeptide lysine in fibroblasts from patients with the homozygous variant (Barnes_2013). The following publication has been ascertained in the context of this evaluation (PMID: 23712425).ClinVar contains an entry for this variant (Variation ID: 208427). Based on the evidence outlined above, the variant was classified as pathogenic. - |
Bruck syndrome 1 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 01, 2013 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Nov 08, 2022 | In-frame deletion of 1 amino acid in a non-repeat region; Not observed in large population cohorts (gnomAD); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 23712425, 34173012) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at